1Weber N C,Schlaek W.Inhalational anaesthetics and cardioprotection.Handb Exp Pharmacol,2008,182:187-207. 被引量：1
2Fleisher L A,Bechman J A,Brown K A,et al.ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery:a report of the American College of Cardiology/American Heart Association Task Force onPractice Guidelines (Writing Committee to Revise the 2002Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography,American Society of Nuclear Cardiology,Heart Rhythm Society,Society of Cardiovascular Anesthesiologists,Society for CardiovascularAngiography and Interventions,Society for Vascular Medicine and Biology,and Society for Vascular Surgery.J Am Coll Cardiol,2007,50:e159-241. 被引量：1
3HuffmyerJ,Raphael J.Physiology and pharmacology ofmyocardial preconditioning and postconditioning.Semin Cardiothorac Vase Anesth,2009,13:5-18. 被引量：1
4De Hert S G,ten Broecke P W,Mertens E,et al.Sevoflurane but not propofol preserves myocardial function in coronary surgery patients.Anesthesiology,2002,97:42-49. 被引量：1
5De Herr S,Vlasselaers D,Bathe R,et al.A comparison of volatile and non volatile agents for cardioprotection during onpump coronary surgery.Anaesthesia,2009,64:953-960. 被引量：1
1Carden DL,Granger DN.Pathophysiology of ischemia-reperfusion injury[J].J Pathol,2000,190:255-266. 被引量：1
2Rasmussen BS,Sollid J,Knudsen L,et al.The release of systemic inflammatory mediators is independent of cardiopulmonary bypass temperature[J].Cardiothorac Vasc Aneth,2007,21(2):191-196. 被引量：1
3Uyar IS,Onal S,Uysal A,et al.Evaluation of systemic inflammatory response in cardiovascular surgery via Interleukin-6,Interleukin-8,and Neopterin[J].Heart Surg Forum,2014,17(1):E13-17. 被引量：1
4Xia WF,Liu Y,Zhou QS,et al.Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery[J].Yonsei Med J,2011,52(2):326-332. 被引量：1
5Watanabe K,Ma M,Wen J,et al.Effects of edaravone in heart of aged rats after Cerebral ischemia-reperfusion injury[J].Biol Pharm Bull,2007,30(2):460-464. 被引量：1
6Inamura Y,Miyamae M,Sugioka S,et al.Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia reperfusion[J].Anesthesia,2010,24(2):215-224. 被引量：1
7De Hert SG,Ten Broecke PW,Mertens E,et al.Sevoflurane but not propofol preserves myocardial function in coronary surgery patients[J].Anesthesiology,2002,97(1):42-49. 被引量：1
8Garcia C,Julier K,Bestmann L,et al.Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery[J].Br J Anaesth,2005,94(2):159-165. 被引量：1
9Wu AH,Lu QA,Todd J,et al.Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay:implications for clinical practice[J].Clin Chem,2009,55(1):52-58. 被引量：1
10Fang NX, Yao YT, Shi CX, et al. Attenuation of ischemia-repeffusion injury by sevoflurane postconditioning invdves protein Kinase B and glycogen synthase kinase 3 beta activation inisdated rat hearts. Mol Bi- d Rep, 2010,37 ( 8 ): 3763-3769. 被引量：1
